Effective April 1, 2026, Marubeni Corporation will transfer part of the Chemicals Division II business to its consolidated subsidiary Marubeni Chemix Corporation through a simplified absorption-type company split; on the same day, Marubeni Chemix will merge with Marubeni Plax and change its trade name to Marubeni Innovexis Corporation.
Revenue for the third quarter of the fiscal year ending March 2026 was 6,172.4 billion yen (up 7.9% YoY), operating income was 190.6 billion yen (down 14.3% YoY), and net income attributable to owners of parent for the quarter was 432.3 billion yen (up 1.7% YoY).
For the cumulative third quarter of the fiscal year ending March 2026, revenue was ¥6,172.4 billion (7.9% increase YoY), and net income attributable to owners of the parent for the quarter was ¥432.3 billion (1.9% increase YoY).
Marubeni Corporation has revised its annual dividend forecast per share for the fiscal year ending March 2026 from ¥100.00 to ¥107.50, and has also raised its year-end dividend forecast from ¥50.00 to ¥57.50 per share.
Marubeni Corporation has resolved to acquire up to 5 million shares of treasury stock (approximately 0.3% of issued shares) within a total purchase price limit of 15 billion yen, during the period from February 5, 2026 to June 30, 2026.
From January 1 to January 30, 2026, Marubeni Corporation acquired 3,996,000 shares of treasury stock totaling 19,687,315,200 yen, and completed the acquisition.
Marubeni Corporation plans to obtain approval at the Annual General Meeting of Shareholders scheduled for June 2026 to transition from a company with a board of statutory auditors to a company with a nomination committee, etc.
Marubeni Corporation plans to propose the transition to a company with a nominating committee system at the Annual General Meeting of Shareholders scheduled for June 2026, and has selected 15 director candidates. Personnel changes include 5 newly appointed director candidates.
An organizational restructuring will be implemented effective April 1, 2026, involving multiple department integrations, abolitions, and new establishments. Executive personnel changes, including the change of President and CEO, are planned after the annual shareholders meeting scheduled for June 2026.
Marubeni Corporation received on January 19, 2026, a judicial review ruling dated December 16, 2024, that annulled the Supreme Court decision concerning the lawsuit with Indonesia’s Sugar Group; there is no impact on the consolidated earnings forecast for the fiscal year ending March 2026.
Acquired 4,081,700 shares of treasury stock totaling 17,609,674,800 yen from December 1 to December 31, 2025. Cumulative acquisition shares total 16,863,400 shares with an acquisition cost of 50,312,578,100 yen.
During the period from August 1 to August 31, 2025, Marubeni Corporation did not acquire any treasury stock. The cumulative number of shares acquired amounts to 12,781,700 shares, and the total acquisition cost is 32,702,903,300 yen.